Form 8-K - Current report:
SEC Accession No. 0001493152-26-030190
Filing Date
2026-06-25
Accepted
2026-06-25 17:22:26
Documents
13
Period of Report
2026-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 45138
2 EX-10.2 ex10-2.htm EX-10.2 22319
3 EX-99.1 ex99-1.htm EX-99.1 21210
  Complete submission text file 0001493152-26-030190.txt   264906

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE vvos-20260625.xsd EX-101.SCH 3005
5 XBRL LABEL FILE vvos-20260625_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE vvos-20260625_pre.xml EX-101.PRE 22352
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3222
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39796 | Film No.: 261123123
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)